Croda International

Uvax Bio to give a Preclinical Development Update on its HIV-1 Vaccine at the World Vaccine Congress – West Coast 2023

Retrieved on: 
Tuesday, November 28, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, AIDS, Health, Infectious Diseases, Associate, Computational biology, Safety, GMP, UFO, HIV-1, Scripps Research, Vaccine, Immunization, CpG, Congress, Rat, Chemistry, Croda International

The presentation will be during the World Vaccine Congress – West Coast in Santa Clara, California on November 30th.

Key Points: 
  • The presentation will be during the World Vaccine Congress – West Coast in Santa Clara, California on November 30th.
  • Zhu added the innovative step to further modify his vaccine with a process called glycan trimming which demonstrated enhanced immune responses in the studies.
  • The 1c-SApNP platform technology and HIV-1 vaccine candidates have been exclusively licensed to Uvax Bio under a comprehensive agreement with Scripps Research.
  • “Our preclinical studies have confirmed both the safety and robust immunogenicity of our vaccine candidates for HIV-1.

American Software Reports Second Quarter of Fiscal Year 2024 Results

Retrieved on: 
Thursday, November 16, 2023
Software, Mobile, Wireless, Supply Chain Management, Networks, Other Retail, Data Management, Specialty, Technology, Artificial Intelligence, Retail, Transport, Other Technology, Logistics, Cloud, Sale, EBITDA, Woman, Acquisition, Workforce, Investment, Depreciation, Date, Coffee, Share repurchase, Hostess Brands, Machine learning, GAAP, Black Rifle Coffee Company, Software as a service, Forecasting, ChatGPT, Information technology, Fiscal, Demand, Publication, Video game, Food delivery, Airline, Drug, Security (finance), Bookkeeping, Maintenance, Croda International

American Software, Inc. (NASDAQ: AMSWA) today reported preliminary financial results for the second quarter of fiscal year 2024.

Key Points: 
  • American Software, Inc. (NASDAQ: AMSWA) today reported preliminary financial results for the second quarter of fiscal year 2024.
  • During the quarter we divested our information technology consulting firm, The Proven Method and its results are included in discontinuing operations.
  • Software license revenues were $0.2 million for the quarter ended October 31, 2023 compared to $0.7 million in the same period last year.
  • During the second quarter of fiscal year 2024, the Company paid shareholder dividends of approximately $3.8 million.

Botanical Solution Inc. (BSI) Wins ICIS Chemical Business 2023 Best Process Innovation Award

Retrieved on: 
Monday, October 23, 2023
Research, Pharmaceutical, Sustainability, Agriculture, Infectious Diseases, Natural Resources, Environment, Science, Chemicals, Plastics, Biotechnology, Manufacturing, Health, Gold standard, FDA, RSV, Gold, Retail Solutions Inc., Syngenta, Centre for Process Innovation, QS-21, Vaccine, Savoy Hotel, Malaria, Savoy, Multimedia, BSI, Award, Nature, COVID, Partnership, Immunotherapy, YOY, Cancer, Shingles, Marketing, Croda International, Pharmaceutical industry, Fine chemical, Central London, EU

Botanical Solution Inc. (BSI), has been named winner of the 2023 Best Process Innovation Award from ICIS Chemical Business.

Key Points: 
  • Botanical Solution Inc. (BSI), has been named winner of the 2023 Best Process Innovation Award from ICIS Chemical Business.
  • View the full release here: https://www.businesswire.com/news/home/20231023605215/en/
    Botanical Solution Inc. (BSI) has received the 2023 Best Process Innovation Award from ICIS Chemical Business for BSI's innovative in-lab process that sustainably scales gold standard solutions for human and plant health.
  • Accepting the 2023 Process Innovation Award on behalf of BSI was Laura Reilly, Croda Pharma’s VP Marketing, who stated, “I’m honored to accept this Award on behalf of Croda’s partner, Botanical Solution.
  • We thank the ICIS Chemical Business team of judges for this honor, as well as our great collaborators Croda Pharma and Syngenta for their valued partnership.”

Dotmatics Releases New Chemicals & Materials Solution Focused on Data-Driven Research to Accelerate Product Development

Retrieved on: 
Wednesday, September 27, 2023
Knowledge, Product management, Informatics, Leverage-point modeling, Learning, Dotmatics, High-performance Integrated Virtual Environment, ELN, Workflow, Research, Global Research, Organization, Formula, Knowledge management, Laboratory information management system, LIMS, R, Formulation, Software, Fine chemical, Medical device, Croda International

BOSTON, Sept. 27, 2023 /PRNewswire/ -- Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced its new Dotmatics Chemicals & Materials Solution specifically designed to help R&D leaders get more insight from their data, faster. With its focus on simplifying data intelligence, the new Dotmatics Chemicals & Materials Solution helps researchers accelerate new product development by enabling data-driven research, simplifying project management, and reducing the complexities of research IT infrastructure. Learn more at: https://www.dotmatics.com/solutions/chemicals-materials-science-software.

Key Points: 
  • With its focus on simplifying data intelligence, the new Dotmatics Chemicals & Materials Solution helps researchers accelerate new product development by enabling data-driven research, simplifying project management, and reducing the complexities of research IT infrastructure.
  • "We are bringing the Dotmatics Chemicals & Materials solution to market specifically to empower teams to gain insights, make informed decisions, and streamline workflows, ultimately driving greater efficiency and productivity."
  • The Dotmatics Chemicals & Materials Solution includes the following workflows and capabilities:
    Ingredient Management: Leverages Dotmatics Bioregister as a general entity registration framework to define and track ingredient properties.
  • The Dotmatics Chemicals & Materials Solution is now generally available to help researchers accelerate new product development.

Logility Clients Receive 2023 Women in Supply Chain Award

Retrieved on: 
Monday, September 25, 2023
Supply Chain Management, Technology, Manufacturing, Transport, Other Manufacturing, Retail, Software, Artificial Intelligence, Logistics, Packaging, Chemicals, Plastics, Demand, Heart, Male, Croda International, Woman, Reynolds, Organization, Food, Lifting, CIO, Growth, SVP, Renewable energy, Supply

Logility, Inc., a leader in prescriptive supply chain planning solutions, announced that Rebecca Springett, Global Process Owner, for Croda and Rita Fisher, CIO and SVP of Supply Chain for Reynolds have been named winners of Supply & Demand Chain Executive’s 2023 Women in Supply Chain Award.

Key Points: 
  • Logility, Inc., a leader in prescriptive supply chain planning solutions, announced that Rebecca Springett, Global Process Owner, for Croda and Rita Fisher, CIO and SVP of Supply Chain for Reynolds have been named winners of Supply & Demand Chain Executive’s 2023 Women in Supply Chain Award.
  • This award honors female supply chain leaders and executives whose accomplishments, mentorship, and examples set a foundation for women in all levels of a company’s supply chain network.
  • As more women join the supply chain workforce, they bring diverse perspectives that can help address complex supply chain problems and improve global supply chain operations.
  • It is important that we empower, recognize, and elevate these achievements through initiatives like the Women in Supply Chain Award, as seen through the overwhelming response,” says Sarah Barnes-Humphrey, founder of Let’s Talk Supply Chain podcast and Blended Pledge project, both exclusive sponsors of the Women in Supply Chain award.

Botanical Solution, Inc. Secures Additional $7 Million, Totaling Over $13 Million in Series A Funding

Retrieved on: 
Wednesday, August 23, 2023
Finance, White House, Federal Government, Banking, State, Local, Public Policy, Professional Services, Philanthropy, Technology, Other Natural Resources, Mining, Minerals, Forest Products, Agriculture, Foundation, Natural Resources, Science, Government, Restaurant, Bar, Packaging, FDA, University, Chemicals, Plastics, Food Tech, Education, Manufacturing, Other Health, Logistics, Supply Chain Management, Pharmaceutical, Environment, Other Science, Research, Clinical Trials, Wine & Spirits, Health, Supermarket, Transport, Retail, Vaccine, GMP, Partnership, BSI, Syngenta, Retail Solutions Inc., Croda International, QS-21, Humberto Díaz Casanueva, YOY, Gold, EU

Botanical Solution Inc. (BSI), the multiple award-winning innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured an additional $7 million investment.

Key Points: 
  • Botanical Solution Inc. (BSI), the multiple award-winning innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured an additional $7 million investment.
  • The successful partnership with Syngenta established since 2019 has produced over 50% YOY growth of effective growers’ adoption of the product in Chile and Peru, accumulating over 100,000 acres treated to date.
  • BSI is on track to start delivering GMP materials to be used in the development of human vaccines later in the year.
  • BSI is in a privileged position to solve major issues affecting the supply chain, cost and sustainability of the vaccine adjuvant QS-21 and addressing major challenges associated with disease control in modern agriculture.”

LBB Specialties' Courtney Flood Promoted to Vice President of Marketing and Business Development

Retrieved on: 
Thursday, August 10, 2023
Business development, Partnership, Chemist, Croda International, Biomolecular engineering, Honors colleges and programs, Flood, White House Conference on Food, Nutrition, and Health, Marketing, New York University Tandon School of Engineering, Columbia University Science Honors Program, LBB, Fine chemical, Engineering, Chemical substance

NORWALK, Conn., Aug. 10, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredients distribution in North America, announced Courtney Flood has been promoted to Vice President of Marketing and Business Development.

Key Points: 
  • NORWALK, Conn., Aug. 10, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredients distribution in North America, announced Courtney Flood has been promoted to Vice President of Marketing and Business Development.
  • "Courtney has been instrumental in the realignment of our commercial organization into industry verticals while onboarding our legacy division acquisitions to join the LBB Specialties platform under one centralized brand," said Hank DeWolf, President and CEO of LBB Specialties.
  • As Vice President of Marketing and Business Development, Flood will also help shape future initiatives in digitization and sustainability, crucial to delivering outstanding service as a technical solutions provider for customers.
  • Flood joined LBB Specialties in 2020 as Director, Life Sciences Marketing and was promoted to Vice President, Marketing in 2021.

LBB Specialties' Courtney Flood Promoted to Vice President of Marketing and Business Development

Retrieved on: 
Thursday, August 10, 2023
Business development, Partnership, Chemist, Croda International, Biomolecular engineering, Honors colleges and programs, Flood, White House Conference on Food, Nutrition, and Health, Marketing, New York University Tandon School of Engineering, Columbia University Science Honors Program, LBB, Fine chemical, Engineering, Chemical substance

NORWALK, Conn., Aug. 10, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredients distribution in North America, announced Courtney Flood has been promoted to Vice President of Marketing and Business Development.

Key Points: 
  • NORWALK, Conn., Aug. 10, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredients distribution in North America, announced Courtney Flood has been promoted to Vice President of Marketing and Business Development.
  • "Courtney has been instrumental in the realignment of our commercial organization into industry verticals while onboarding our legacy division acquisitions to join the LBB Specialties platform under one centralized brand," said Hank DeWolf, President and CEO of LBB Specialties.
  • As Vice President of Marketing and Business Development, Flood will also help shape future initiatives in digitization and sustainability, crucial to delivering outstanding service as a technical solutions provider for customers.
  • Flood joined LBB Specialties in 2020 as Director, Life Sciences Marketing and was promoted to Vice President, Marketing in 2021.

Croda and Botanical Solution Inc. (BSI) Announce Partnership to Accelerate Production of Sustainable Vaccine Adjuvant QS-21

Retrieved on: 
Monday, May 22, 2023
Biotechnology, Health, Pharmaceutical, Forest Products, Agriculture, Natural Resources, Research, Infectious Diseases, Environment, Science, Sustainability, Vaccine, GMP, Pharma, Partnership, BSI, Administration, Tree, Cancer, Lipid, QS-21, Multimedia, Shingles, Immunotherapy, ABM, Delaware General Corporation Law, Excipient, RSV, Gold, Investment, Laboratory, Biomass, News, Malaria, Pharmaceutical industry, Croda International, Quillaja

View the full release here: https://www.businesswire.com/news/home/20230522005663/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230522005663/en/
    Croda and Botanical Solution Inc. (BSI) announce partnership to accelerate production of sustainable vaccine adjuvant QS-21.
  • Pictured is the Croda - BSI partnership team in the BSI laboratories in Santiago, Chile.
  • BSI, a Delaware Corporation, has a proprietary R&D platform for truly sustainable and improved production of consistent and high-quality Advanced Botanical Materials (ABM).
  • ABM-01 is the active ingredient used in two gold standard products, BSI’s biopesticide Quillibrium® and the adjuvant QS-21, used in modern vaccine development.

AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE

Retrieved on: 
Friday, May 19, 2023
Partnership, Administration, Squalene, Sustainability, Sale, Shark, Beauty, CGMP, Health, International, Vaccine, Pharmaceutical industry, Croda International, Amyris

Amyris' squalene is a biofermentation-based adjuvant developed using Amyris' unique Lab-to-Market technology platform.

Key Points: 
  • Amyris' squalene is a biofermentation-based adjuvant developed using Amyris' unique Lab-to-Market technology platform.
  • Amyris' sugarcane-derived, sustainable squalene is molecularly identical to the traditional shark source, offering a higher purity and a more predictable cost profile compared to sourcing directly from sharks.
  • Under the terms of the agreement, Amyris will manufacture and supply squalene to Croda and Croda will license squalene technology from Amyris to market, distribute, and sell squalene as an excipient, or as an ingredient in formulated products for use in human and veterinary vaccines, drug delivery systems, or nucleic acid delivery systems.
  • "We are pleased to partner with Croda to increase access to our sustainable squalene.